– Today, Canopy announced that it will launch in secret with $13 million in funding to partner with the nation’s leading oncology practices to help provide high-quality care for cancer patients when not in a doctor’s office.
– Canopy partners with the nation’s leading oncology practices to deliver the best outcomes for more than 50,000 cancer patients.
Canopy, a Palo Alto, California-based oncology intelligent care platform (ICP), announced today that it has raised $13 million in funding led by GSR Ventures with participation from Samsung Next, UpWest, and other industry leaders and executives including Geoff Among them are Calkins (former SVP of Product at Flatiron Health) and Chris Mansi (CEO of Viz.AI).Canopy, formerly known as Expain, is also launching privately today to make its platform generally available to cancer treatment centers across the U.S.
Kwiatkowsky, who founded Canopy in 2018, has previously had hands-on engagement with the healthcare system, highlighting the challenges posed by today’s respite care, especially in complex disease areas such as oncology.Through this process, he realized that nursing teams were overwhelmed with information, tasks, and challenges, limiting their ability to employ important technologies to improve care.This experience gave Canopy a key insight: “In order to help patients, you first need to help practice.” Before founding Canopy, he spent the past 16 years in Israel’s elite intelligence services and later in Israeli startups Work to lead large-scale projects related to data processing, artificial intelligence and machine learning.
Due to the transient and episodic nature of in-office cancer care, up to 50% of patients’ symptoms and treatment side effects will go undetected.This often results in avoidable hospital visits and poor experiences, and more importantly, potentially harmful treatment interruptions that compromise the patient’s chances of survival.This is exacerbated during the pandemic as oncologists rely on spreadsheets, phone calls and other manual processes that are inefficient, costly and unsustainable.Research shows that remote monitoring of patients undergoing cancer treatment can improve quality of life, satisfaction, and overall survival, but providers lack the tools to deliver remote and proactive care.
Canopy revolutionizes this model by enabling physicians to continuously and proactively interact with patients.Canopy’s Smart Care Platform includes a comprehensive suite of intelligent, electronic health record integration tools that help cancer centers continuously interact with patients, streamline clinical workflows, and capture new reimbursement streams for their meaningful work.As a result, care teams can better shift resources from repetitive manual work to supporting patients who need them most, improving patient outcomes at a lower cost.
Canopy’s platform, in partnership with the nation’s leading oncology practice, demonstrated high patient enrollment (86%), participation (88%), retention (90% at 6 months) and timely care intervention rates (88 %).Clinical results from Canopy, due in 2022, show a reduction in emergency department utilization and hospital admissions, as well as an increase in treatment time.
Canopy is a Preferred Provider of the Quality Cancer Care Alliance (QCCA) and partners with leading oncology practices across the country, including Highlands Oncology Group, North Florida Cancer Specialists, Northwestern Medicine Specialties, Los Angeles Cancer Network, Western Cancer and Hematology Center Michigan and Tennessee Cancer Specialists (TCS).
“Canopy’s mission is to provide the best possible outcomes and experience for everyone undergoing cancer treatment,” said Lavi Kwiatkowsky, founder and CEO of Canopy.”We’ve demonstrated in cancer treatment centers across the U.S. that proactive care delivery models are not only possible, but effective. Now, we’re focused on expanding our national presence while increasingly deploying artificial intelligence, to maximize the benefits we bring to patients and their care teams.”
Tagged With: artificial intelligence, artificial intelligence, cancer, care teams, clinical workflow, flatiron health, machine learning, models, oncology, oncology digital health startups, oncology platforms, patient experience, doctors, samsung
Post time: Mar-23-2022
